Literature DB >> 26483441

Exposure rate of unwrapped hydroxyapatite orbital implants in enucleation surgery.

Juan Ye1, Qi Gao1, Jin-Jing He1, Tao Gao1, Qing-Yao Ning1, Jia-Jun Xie1.   

Abstract

OBJECTIVE: To document the long-term exposure rate of unwrapped coralline hydroxyapatite (HA) orbital implants and explore possible risk factors.
DESIGN: This retrospective case series (May 2008-April 2013) reviewed the 234 patients with anophthalmia who underwent insertion of an unwrapped HA orbital implant by one of two different surgical closing techniques.
RESULTS: Of the 234 cases, 151 underwent a rectus end-to-end suturing closure technique and 83 underwent a rectus orthotopic suturing closure technique. The time of follow-up ranged from 25 months to 69 months (mean 41.9 months). Implant exposure developed in 11 cases. Three in the rectus end-to-end suturing closure group (2.0%) and eight in the rectus orthotopic suturing closure group (9.6%). In the rectus end-to-end suturing technique, a crosswise fixation of vascularised rectus muscle tissue is formed across the front of the implant; in this group the incidence of implant exposure was reduced (OR=8.11, p=0.013). Prior ocular surgery was found to be a factor increasing the incidence of HA exposure (OR=2.73, p=0.032).
CONCLUSIONS: The placement of an unwrapped HA orbital implant with rectus end-to-end suturing in enucleation surgery was associated with a low rate of exposure in most cases. The end-to-end suturing creates a joint-like structure over the HA sphere, protecting the Tenon's capsule and conjunctiva from its rough surface and reducing the risk of implant exposure. Prior ocular surgery may be another risk factor for HA exposure. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Cosmesis; Treatment Surgery

Mesh:

Substances:

Year:  2015        PMID: 26483441     DOI: 10.1136/bjophthalmol-2015-307412

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Orbital implant exposure following enucleation or evisceration.

Authors:  Huda Abdullah Al-Farsi; Buthaina Issa Sabt; Abdullah Said Al-Mujaini
Journal:  Oman J Ophthalmol       Date:  2017 May-Aug

2.  An accurate interactive segmentation and volume calculation of orbital soft tissue for orbital reconstruction after enucleation.

Authors:  Qingyao Ning; Xiaoyao Yu; Qi Gao; Jiajun Xie; Chunlei Yao; Kun Zhou; Juan Ye
Journal:  BMC Ophthalmol       Date:  2019-12-16       Impact factor: 2.209

3.  Biological activity of a vascular endothelial cell-hydroxyapatite orbital implant complex: An experimental study.

Authors:  Weiqi Wu; Hao Luo; Dan Wu; Menglin Shi; Jinhai Yu; Hongfei Liao
Journal:  Exp Ther Med       Date:  2022-01-18       Impact factor: 2.447

4.  Next-generation finely controlled graded porous antibacterial bioceramics for high-efficiency vascularization in orbital reconstruction.

Authors:  Jingyi Wang; Yiyu Peng; Menglu Chen; Xizhe Dai; Lixia Lou; Changjun Wang; Zhaonan Bao; Xianyan Yang; Zhongru Gou; Juan Ye
Journal:  Bioact Mater       Date:  2022-01-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.